We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $4.64B
1-Year Est. Return 38.78%
This Fund
S&P 500
This Quarter Est. Return
+0.89%
1 Year Est. Return
+38.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.64B
AUM Growth
-$11.3M
Cap. Flow
+$216M
Cap. Flow %
4.66%
Top 10 Hldgs %
29.33%
Holding
940
New
170
Increased
287
Reduced
322
Closed
160

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$33.6M
2
V icon
Visa
V
+$31.8M
3
QCOM icon
Qualcomm
QCOM
+$26.1M
4
MS icon
Morgan Stanley
MS
+$23.3M
5
META icon
Meta Platforms (Facebook)
META
+$22.1M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$26M
2
LRCX icon
Lam Research
LRCX
+$24.5M
3
LMT icon
Lockheed Martin
LMT
+$22.3M
4
BSX icon
Boston Scientific
BSX
+$20.3M
5
UNP icon
Union Pacific
UNP
+$19.5M

Sector Composition

Rank Sector Weight
1 Technology 29.05%
2 Financials 12.66%
3 Healthcare 12.35%
4 Industrials 11.22%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVST icon
776
Microvast
MVST
$256M
$44K ﹤0.01%
+29,339
New +$70.7K
LPL icon
777
LG Display
LPL
$2.93B
$41.6K ﹤0.01%
10,729
-54,524
-84% -$230K
HLLY icon
778
Holley
HLLY
$336M
$40.4K ﹤0.01%
13,153
-20,299
-61% -$76.9K
OPTU
779
Optimum Communications Inc
OPTU
$298M
$19.8K ﹤0.01%
15,210
+1,017
+7% +$1.6K
XRXDW
780
Xerox Holdings Corp Warrants
XRXDW
$19M
$3.73K ﹤0.01%
+41,265
New +$4.54K
ABUS icon
781
Arbutus Biopharma
ABUS
$871M
-16,387
Closed -$78.8K
ACVA icon
782
ACV Auctions
ACVA
$1.43B
-28,727
Closed -$230K
AI icon
783
C3.ai
AI
$1.38B
-49,059
Closed -$661K
ALLY icon
784
Ally Financial
ALLY
$13.4B
-6,054
Closed -$274K
ALTO icon
785
Alto Ingredients
ALTO
$345M
-32,236
Closed -$92.8K
OSG
786
Octave Specialty Group
OSG
$261M
-11,204
Closed -$87.2K
AMBP icon
787
Ardagh Metal Packaging
AMBP
$3.11B
-16,982
Closed -$69.6K
AOS icon
788
A.O. Smith
AOS
$8.82B
-10,272
Closed -$687K
APA icon
789
APA Corp
APA
$12.3B
-20,851
Closed -$510K
APG icon
790
APi Group
APG
$17B
-8,781
Closed -$336K
APPN icon
791
Appian
APPN
$2.01B
-7,703
Closed -$273K
AQST icon
792
Aquestive Therapeutics
AQST
$472M
-14,044
Closed -$90.7K
ARM icon
793
Arm
ARM
$261B
-31,687
Closed -$3.46M
ASPN icon
794
Aspen Aerogels
ASPN
$364M
-19,675
Closed -$55.7K
ASR icon
795
Grupo Aeroportuario del Sureste
ASR
$8.14B
-2,181
Closed -$705K
AVDL
796
DELISTED
Avadel Pharmaceuticals
AVDL
-153,607
Closed -$3.31M
AXTI icon
797
AXT Inc
AXTI
$2.8B
-121,225
Closed -$1.98M
AYI icon
798
Acuity Brands
AYI
$10.3B
-2,707
Closed -$975K
AZN icon
799
AstraZeneca
AZN
$267B
-7,863
Closed -$1.45M
BANF icon
800
BancFirst
BANF
$3.89B
-2,658
Closed -$282K

Similar funds

Voleon Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Voleon Capital Management held 940 positions worth $4.64B, down 0.24% from $4.65B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management deployed $216M of net new capital in Q1 2026, opening 170 new positions and adding to 287 existing holdings. Its largest new stake was Solstice Advanced Materials: 189,549 shares worth $14.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Honeywell, an estimated $26M trimmed.

  • Voleon Capital Management's largest Q1 2026 buy was Solstice Advanced Materials: 189,549 shares worth $14.4M.
  • Voleon Capital Management added most to Eli Lilly in Q1 2026, an estimated $33.6M increase.
  • Voleon Capital Management's biggest Q1 2026 reduction was Honeywell, cutting an estimated $26M.
  • Voleon Capital Management fully exited REV Group in Q1 2026, selling an estimated $4.18M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $4.64B portfolio in Q1 2026.
  • Voleon Capital Management opened 170 new positions and closed 160 in Q1 2026.
  • Voleon Capital Management's portfolio value fell 0.24% quarter-over-quarter to $4.64B.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.